6th CKD Drug Development Summit: Countdown Begins

The approval is based on three Phase III studies evaluating the safety and efficacy of the drug. Credit: Ildo Frazao via Getty Images. The US

With a new pres­i­den­tial ad­min­is­tra­tion next year, FDA Prin­ci­pal Deputy Com­mis­sion­er Na­mand­jé Bum­pus would be in line to lead the agency if cur­rent Com­mis­sion­er Robert